If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine.

Aug 4 (Reuters) - Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against ...

Moderna (NasdaqGS:MRNA) has initiated a Phase 1 clinical trial in Canada for its investigational mRNA vaccine targeting ...

Moderna’s vaccine candidate targets a species of ebolavirus behind a deadly outbreak in the Democratic Republic of the Congo.

The first participant in Moderna's trial of a new Ebola vaccine received the vaccine in Truro, N.S., on Monday.

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines ...

Moderna has begun a Phase 1 clinical trial of an Ebola vaccine set to target the Bundibugyo strain, which is currently ...

The program is backed by the Coalition for Epidemic Preparedness Innovations, which has committed up to $50 million.

Moderna has started first-in-human testing of its mRNA vaccine against Bundibugyo Ebola virus (BDBV), now causing the ...

The vaccine relies on the same mRNA technology used in Moderna’s Covid-19 vaccine. Read more at straitstimes.com. Read more ...

Canada is now the second country to authorize a Phase I clinical trial for a Bundibugyo virus vaccine candidate after the U.K ...

Moderna has launched the world's first Phase 1 trial of a Bundibugyo Ebola mRNA vaccine, targeting an Ebola strain that still ...